| # | Drug | Count |
|---|---|---|
| 0 | BISOPROLOL FUMARATE | 2 |
| 1 | CEFUROXIME | 2 |
| 2 | CLOPIDOGREL | 2 |
| 3 | CLOPIDOGREL BISULFATE | 2 |
| 4 | DICLOFENAC | 2 |
| 5 | DICLOFENAC SODIUM | 2 |
| 6 | OMEGA-3-ACID ETHYL ESTERS | 2 |
| 7 | CARBOPLATIN | 1 |
| 8 | ENALAPRIL | 1 |
| 9 | INFLIXIMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMEGA-3-ACID ETHYL ESTERS | 2 | 0.0010 |
| 1 | CEFUROXIME | 2 | 0.0002 |
| 2 | TOPOTECAN | 1 | 0.0002 |
| 3 | MYCOPHENILIC ACID | 1 | 0.0000 |
| 4 | MELPHALAN HYDROCHLORIDE | 1 | 0.0000 |
| 5 | MYCOPHENOLIC ACID | 1 | 0.0000 |
| 6 | IPILIMUMAB | 1 | 0.0000 |
| 7 | CLOPIDOGREL BISULFATE | 2 | 0.0000 |
| 8 | ENALAPRIL | 1 | 0.0000 |
| 9 | BISOPROLOL FUMARATE | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 2 | P2Y12 Platelet Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 1 | 0.0000 |